- Home
- AUPH vs UTL Comparison
AUPH vs UTL Comparison
Compare AUPH & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | UTL |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 906.9M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AUPH | UTL |
|---|---|---|
| Price | $16.36 | $50.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $17.25 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 700.4K | 96.0K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | ★ 5075.00 | 1.37 |
| EPS | 0.53 | ★ 2.11 |
| Revenue | $283,055,000.00 | ★ $536,000,000.00 |
| Revenue This Year | $17.54 | $5.43 |
| Revenue Next Year | $15.74 | $4.22 |
| P/E Ratio | $30.92 | ★ $24.16 |
| Revenue Growth | ★ 20.38 | 8.33 |
| 52 Week Low | $10.92 | $46.40 |
| 52 Week High | $19.25 | $57.26 |
Technical Indicators
Market Signals| Indicator | AUPH | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 50.61 | 37.22 |
| Support Level | $15.65 | $50.41 |
| Resistance Level | $16.40 | $51.58 |
| Average True Range (ATR) | 0.42 | 1.22 |
| MACD | -0.03 | -0.19 |
| Stochastic Oscillator | 38.89 | 43.82 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About UTL UNITIL Corporation
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.